Glatiramer Acetate
Glatiramer acetate (GA) is a synthetic amino acid copolymer that is approved for treatment of relapsing remitting multiple sclerosis (RRMS) and clinically isolated syndrome (CIS) . (In Vitro) :Glatiramer acetate (25-100 mg/kg; S.c; 5 days) increase BDNF levels.In huntington’s disease (HD) mouse model, the N171-82Q transgenic mouse line, which exhibits a more rapidly progressing disease course. Glatiramer acetate (1 mg/mouse; s.c.; 5xweek) beginning at 8 weeks of age and continuing until 20 weeks of age, which is near the age of death due to the disease. Glatiramer acetate elicited improves performance on several motor function measures. Glatiramer acetate significantly improves the performance of N171-82Q transgenic mice at 15 weeks of age in the rotarod test measured over the course of 4 days.
Product Specifications
CAS Number
147245-92-9
Purity
>98% (HPLC)
Solubility
DMSO:Insoluble; Water:10 mM
Smiles
C[C@@H] (C (=O) O) N.CC (=O) O.C1=CC (=CC=C1C[C@@H] (C (=O) O) N) O.C (CCN) C[C@@H] (C (=O) O) N.C (CC (=O) O) [C@@H] (C (=O) O) N
Molecular Formula
C25H45N5O13
Molecular Weight
623.65
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![1- (4-chloro-3-nitrophenyl) -2-{[5- (4-pentylphenyl) -4H-1,2,4-triazol-3-yl]thio}ethan-1-one](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
1- (4-chloro-3-nitrophenyl) -2-{[5- (4-pentylphenyl) -4H-1,2,4-triazol-3-yl]thio}ethan-1-one
TPD52L2 Polyclonal Antibody, Biotin Conjugated